1. |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2):87-108.
|
2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2):115-132.
|
3. |
Black WC, Gareen IF, Soneji SS, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med, 2014, 371(19):1793-1802.
|
4. |
Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5):395-409.
|
5. |
袁金秋, 刘雅莉, 杨克虎, 等. 系统评价再评价纳入研究的质量评价方法调查. 中国循证医学杂志, 2012, 12(2):238-242.
|
6. |
Tammemägi MC, Katki HA, Hocking WG, et al. Selection Criteria for Lung-Cancer Screening. N Engl J Med, 2013, 368(8):728-736.
|
7. |
Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer:U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 2014, 160(5):330-338.
|
8. |
Whiting P, Savović J, Higgins JP, et al. ROBIS group, ROBIS:A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol, 2016, 69:225-234.
|
9. |
Guyatt GH, Oxman AD, Vist GE, et al. GRADE:an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650):924-926.
|
10. |
Manser RL, Irving LB, Byrnes G, et al. Screening for lung cancer:a systematic review and meta-analysis of controlled trials. Thorax, 2003, 58(9):784-789.
|
11. |
Yau G, Lock M, Rodrigues G. Systematic review of baseline low-dose CT lung cancer screening. Lung Cancer, 2007, 58(2):161-170.
|
12. |
Black C, de Verteuil R, Walker S, et al. Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature. Thorax, 2007, 62(2):131-138.
|
13. |
Gopal M, Abdullah SE, Grady JJ, et al. Screening for lung cancer with low-dose computed tomography:a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol, 2010, 5(8):1233-1239.
|
14. |
尚文丽, 张和平, 杨拴盈, 等. 低剂量螺旋CT对高危人群肺癌筛查价值的Meta分析. 西安交通大学学报(医学版), 2011, 32(1):38-42.
|
15. |
惠珍珍. 低剂量CT与X线胸片对肺癌高危人群筛查的meta分析. 济南:山东大学, 2011.
|
16. |
Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer:a systematic review. JAMA, 2012, 307(22):2418-2429.
|
17. |
Chien CR, Liang JA, Chen JH, et al. Fluorodeoxyglucose-positron emission tomography screening for lung cancer:a systematic review and meta-analysis. Cancer Imaging, 2013, 13(4):458-465.
|
18. |
Manser R, Lethaby A, Irving LB, et al. Screening for lung cancer. Cochrane Database Syst Rev, 2013, 6:CD001991.
|
19. |
Humphrey L, Deffebach M, Pappas M, et al. Screening for Lung Cancer:Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Rockville (MD):Agency for Healthcare Research and Quality (US), 2013.
|
20. |
Ollier M, Chamoux A, Naughton G, et al. Chest CT scan screening for lung cancer in asbestos occupational exposure:a systematic review and meta-analysis. Chest, 2014, 145(6):1339-1346.
|
21. |
IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington, DC:The National Academies Press, 2011.
|
22. |
陈耀龙, 杨克虎, 田金徽, 等. 循证实践指南的制定:国际经验与中国实践. 兰州大学学报(医学版), 2016, 42(1):29-35.
|
23. |
杨克虎, 刘雅莉, 袁金秋, 等. 发展和完善中的系统评价再评价. 中国循证儿科杂志, 2011, 6(1):54-57.
|
24. |
田金徽, 陈耀龙, 杨克虎, 等. SR/MA研究进展与挑战. 兰州大学学报(医学版), 2016, 42(1):42-46.
|
25. |
熊俊, 陈日新. 系统评价/Meta分析方法学质量的评价工具AMSTAR. 中国循证医学杂志, 2011, 11(9):1084-1089.
|
26. |
吴琼芳, 丁泓帆, 邓围, 等. ROBIS:评估系统评价偏倚风险的新工具. 中国循证医学杂志, 2015, 15(12):1454-1457.
|
27. |
丁泓帆, 吴琼芳, 杨楠, 等. 评估系统评价偏倚风险的ROBIS工具实例解读. 中国循证医学杂志, 2016, 16(1):115-121.
|
28. |
Available at:http://www.crd.york.ac.uk/PROSPERO.
|
29. |
Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines:3. Rating the quality of evidence. J Clin Epidemiol, 2011, 64(4):401-406.
|